The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell ... MSN: These Diabetes Drugs Are Finding New Life as an Antiaging Hack Some health-obsessed Americans believe the next antiaging therapeutic already exists—in the medicine cabinets of millions of diabetes patients. The widely used class of drugs, called SGLT2 inhibitors ...

Understanding the Context

News Medical: Weight loss drug tirzepatide may lower the risk of diabetic retinopathy You might have heard about medications like Ozempic®, Mounjaro®, and metformin for weight loss. But these drugs are actually diabetes medications that are sometimes prescribed off-label for weight ... McKnight's Long-Term Care News: Two diabetes drugs cut risk of hospitalization for heart failure by 40 percent, study finds Adding to a growing body of research about the related health benefits of diabetes weight-loss drugs, an August 31 study in the Journal of the American Medical Association found that semaglutide and ... Two diabetes drugs cut risk of hospitalization for heart failure by 40 percent, study finds